These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24997695)

  • 1. Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation.
    Berry RS; Gullapalli RR; Wu J; Morris K; Hanson JA
    Virchows Arch; 2014 Aug; 465(2):241-5. PubMed ID: 24997695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamine synthetase interpretation in hepatocellular adenoma.
    Balabaud C; Bioulac-Sage P
    Virchows Arch; 2014 Oct; 465(4):495-6. PubMed ID: 25216583
    [No Abstract]   [Full Text] [Related]  

  • 3. Authors' response.
    Berry RS; Hanson JA
    Virchows Arch; 2014 Oct; 465(4):497-8. PubMed ID: 25148867
    [No Abstract]   [Full Text] [Related]  

  • 4. Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.
    Hale G; Liu X; Hu J; Xu Z; Che L; Solomon D; Tsokos C; Shafizadeh N; Chen X; Gill R; Kakar S
    Mod Pathol; 2016 Nov; 29(11):1370-1380. PubMed ID: 27469330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma arising in a pigmented telangiectatic adenoma with nuclear β-catenin and glutamine synthetase positivity: case report and review of the literature.
    Hechtman JF; Raoufi M; Fiel MI; Taouli B; Facciuto M; Schiano TD; Blouin AG; Thung SN
    Am J Surg Pathol; 2011 Jun; 35(6):927-32. PubMed ID: 21572265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Limited Immunohistochemical Panel Can Subtype Hepatocellular Adenomas for Routine Practice.
    Larson BK; Guindi M
    Am J Clin Pathol; 2017 Jun; 147(6):557-570. PubMed ID: 28472207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
    Shafizadeh N; Genrich G; Ferrell L; Kakar S
    Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas.
    Saldarriaga J; Bisig B; Couchy G; Castain C; Zucman-Rossi J; Balabaud C; Sempoux C; Bioulac-Sage P
    Histopathology; 2017 Dec; 71(6):989-993. PubMed ID: 28618047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The enigma of glutamine synthetase and b-catenin expression in hepatocellular adenoma in familial adenomatous polyposis coli.
    Gouw ASH; Sempoux C; Bioulac-Sage P
    Virchows Arch; 2024 Apr; 484(4):553-554. PubMed ID: 38453738
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatocellular adenoma in Taiwan: Distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype.
    Huang WC; Liau JY; Jeng YM; Liu KL; Lin CN; Song HL; Tsai JH
    J Gastroenterol Hepatol; 2020 Apr; 35(4):680-688. PubMed ID: 31698521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.
    Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J
    Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.
    Kakar S; Grenert JP; Paradis V; Pote N; Jakate S; Ferrell LD
    Mod Pathol; 2014 Nov; 27(11):1499-1509. PubMed ID: 24743216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.
    Margolskee E; Bao F; de Gonzalez AK; Moreira RK; Lagana S; Sireci AN; Sepulveda AR; Remotti H; Lefkowitch JH; Salomao M
    Diagn Pathol; 2016 Mar; 11():27. PubMed ID: 26961851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
    Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
    Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice.
    van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN
    J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of hepatocellular adenomas based on the phenotypic classification system: A report from China.
    Pan J; Chen L; Fan J; Zhou J; Qin L; Tan Y; Ji Y; Huang X
    Histol Histopathol; 2014 Feb; 29(2):243-9. PubMed ID: 23939475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of liver fatty acid binding protein-deficient hepatocellular adenomas: histopathologic spectrum of a rare phenomenon.
    Putra J; Ferrell LD; Gouw ASH; Paradis V; Rishi A; Sempoux C; Balabaud C; Thung SN; Bioulac-Sage P
    Mod Pathol; 2020 Apr; 33(4):665-675. PubMed ID: 31570768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic profiling of well-differentiated hepatocellular neoplasms with diffuse glutamine synthetase staining reveals similar genetics across the adenoma to carcinoma spectrum.
    Joseph NM; Umetsu SE; Shafizadeh N; Ferrell L; Kakar S
    Mod Pathol; 2019 Nov; 32(11):1627-1636. PubMed ID: 31189995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.
    Bioulac-Sage P; Cubel G; Taouji S; Scoazec JY; Leteurtre E; Paradis V; Sturm N; Nhieu JT; Wendum D; Bancel B; Ramos J; Paraf F; Saint Paul MC; Michalak S; Fabre M; Guettier C; Le Bail B; Zucman-Rossi J; Balabaud C
    Am J Surg Pathol; 2012 Nov; 36(11):1691-9. PubMed ID: 23060349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Patterns of Glutamine Synthetase Immunohistochemical Staining in CTNNB1-mutated Hepatocellular Adenomas.
    Sempoux C; Gouw ASH; Dunet V; Paradis V; Balabaud C; Bioulac-Sage P
    Am J Surg Pathol; 2021 Apr; 45(4):477-487. PubMed ID: 33560657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.